Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A meta-analysis to assess the risk of bleeding and thrombosis following chimeric antigen receptor T-cell therapy: Communication from the ISTH SSC Subcommittee on Hemostasis and Malignancy

Journal of Thrombosis and Haemostasis(2024)10.1016/j.jtha.2024.03.021Source: DataRank Database

A meta-analysis to assess the risk of bleeding and thrombosis following chimeric antigen receptor T-cell therapy: Communication from the ISTH SSC Subcommittee on Hemostasis and Malignancy is a research paper published in Journal of Thrombosis and Haemostasis (2024). On theSindex it has a DataRank of 0. It has been cited 21 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access21 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 2.95)OA: bronzeTopics (52)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Rushad Patell ORCID,Thita Chiasakul ORCID,Mandy N. Lauw ORCID,Amica Ko,Tzu‐Fei Wang ORCID

Live enrichment

PubMed:38574863 PMC:PMC11437522 OpenAlex:https://openalex.org/W4393408771

National Cancer Institute

Grant: P30 CA008748

Incyte

National Institutes of Health

CSL Behring

FWCI

2.95

Citation Percentile

0.9%

Citation Trend

2024

2025

2026

bronzeLicense: http://www.elsevier.com/open-access/userlicense/1.0/

journalhttp://www.jthjournal.org/article/S1538783624001806/pdf

publisherhttp://www.jthjournal.org/article/S1538783624001806/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1538783624001806?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1538783624001806?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jtha.2024.03.021

Fields of Study

CAR-T cell therapy researchVirus-based gene therapy researchCutaneous lymphoproliferative disorders researchHumansHemorrhageImmunotherapy, AdoptiveThrombosisHematologic NeoplasmsRisk AssessmentRisk FactorsTreatment OutcomeHemostasisReceptors, Chimeric AntigenAnticoagulantsMaleFemaleMiddle AgedPlatelet Aggregation InhibitorsAdultAged

MeSH Terms

Receptors, Chimeric AntigenAdultAgedAnticoagulantsFemaleHemorrhageHemostasisHumansMaleMiddle AgedPlatelet Aggregation InhibitorsRisk FactorsThrombosisImmunotherapy, AdoptiveTreatment OutcomeRisk AssessmentHematologic Neoplasms

Keywords

MedicineHemostasisInternal medicineMalignancyThrombosisVenous thrombosisMeta-analysisIncidence (geometry)Chimeric antigen receptorGastroenterologyCancerImmunotherapyBleedingSystematic reviewAdoptive immunotherapy

Sustainable Development Goals

SDG 0: Zero hunger